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Abstract. 
 
Normal adult human dermal fibroblasts 
grown in a three-dimensional collagen lattice increase 
 
mRNA level of collagen receptor integrin subunit 
 
a
 
2
 
 
 
(Xu, J., and R.A.F. Clark. 1996. 
 
J. Cell Biol.
 
 132:239–
249.) and DNA binding activity of a nuclear transcrip-
tion factor, NF-
 
k
 
B (Xu, J., and R.A.F. Clark. 1997. 
 
J. 
Cell Biol.
 
 136:473–483.). Here we present evidence that 
the collagen lattice induced the nuclear translocation of 
p50, one member of NF-
 
k
 
B family, and the degradation 
of an NF-
 
k
 
B inhibitor protein, I
 
k
 
B-
 
a
 
. The inhibition of 
NF-
 
k
 
B activity by SN50, a peptide inhibitor targeted at 
nuclear translocation of NF-
 
k
 
B, significantly reduced 
the induction of integrin 
 
a
 
2
 
 mRNA and protein by the 
collagen lattice. A region located between 
 
2
 
549 and 
 
2
 
351 bp in the promoter of integrin 
 
a
 
2
 
 gene conferred 
the inducibility by three-dimensional collagen lattice. 
The presence of either SN50 or I
 
k
 
B-
 
a
 
32, 36
 
, a stable mu-
tant of I
 
k
 
B-
 
a
 
, abrogated this inducibility, indicating 
that the activation of integrin 
 
a
 
2
 
 gene expression was 
possibly mediated by NF-
 
k
 
B through this region. Al-
though there were three DNA–protein binding com-
plexes forming in this region that are sensitive to the in-
hibition of NF-
 
k
 
B nuclear translocation, NF-
 
k
 
B was 
not directly present in the binding complexes. There-
fore, an indirect regulatory mechanism by NF-
 
k
 
B in in-
tegrin 
 
a
 
2
 
 gene expression induced by three-dimensional 
collagen lattice is suggested. The involvement of NF-
 
k
 
B 
in reorganization and contraction of three-dimensional 
collagen lattice, a process that requires the presence 
of abundant integrin 
 
a
 
2
 
b
 
1
 
, was also examined. The inhi-
bition of NF-
 
k
 
B activity by SN50 greatly blocked the 
contraction, suggesting its critical role in not only the 
induction of integrin 
 
a
 
2
 
 gene expression by three-
dimensional collagen lattice, but also 
 
a
 
2
 
b
 
1
 
-mediated 
tissue-remodeling process.
 
T
 
hree-dimensional 
 
(3D)
 
1
 
 extracellular matrix (ECM)
culture systems have been developed to simulate
natural interactions between cells and ECM envi-
ronment. Fibroblasts cultured in type I collagen matrix can
exert forces sufficient to contract the hydrated lattice into
dense organized structures resembling dermis. The align-
ment of collagen fibers that occurs during the embryonic
formation of tendons and ligaments and the contraction of
collagenous tissue that occurs in healing wounds are
thought to be under the influence of the same forces (for
review see Grinnell, 1994). Accompanying is the altered
expression of a group of genes including integrin 
 
a
 
2
 
 (Klein
et al., 1991), type I matrix metalloproteinase (MMP-1;
Langholz et al., 1995), and type I collagen (Eckes et al.,
1993) in these fibroblasts. Therefore, 3D collagen lattice
(COL) may elicit unique signaling processes leading to the
altered expression of related genes and the ability of fibro-
blasts to mediate tissue remodeling.
Integrin 
 
a
 
2
 
b
 
1
 
 is a heterodimeric adhesive protein recep-
tor belonging to the 
 
b
 
1
 
 subfamily. It serves as a collagen
receptor on fibroblasts and platelets and additionally as a
laminin receptor on epithelial and endothelial cells (Elices
and Hemler, 1989; Languino et al., 1989; Kirchhofer et al.,
1990). Functions mediated by 
 
a
 
2
 
b
 
1
 
 may include cell differ-
entiation, motility and metastasis (Chan et al., 1991; Skin-
ner et al., 1994; Keely et al., 1995; Zutter et al., 1995
 
a
 
; Do-
err and Jones, 1996). For example, the loss of 
 
a
 
2
 
b
 
1
 
 in
breast epithelial cells is correlated with the transformed
phenotype (Keely et al., 1995; Zutter et al., 1995
 
a
 
). The in-
teraction of 
 
a
 
2
 
b
 
1
 
 integrin with extracellular type I collagen
in a 3D polymerized structure has been reported to result
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k
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k
 
B, nuclear factor 
 
k
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b
 
; TNF, tumor necrosis factor.
  
The Journal of Cell Biology, Volume 140, 1998 710
 
in the reorganization and contraction of a hydrated col-
lagen matrix (Schiro et al., 1991), and the increased ex-
pression of MMP-1 (Riikonen et al., 1995
 
a
 
).
The expression of 
 
a
 
2
 
b
 
1
 
 is a regulated cellular process. In
addition to 3D COL, the regulatory signals for 
 
a
 
2
 
b
 
1
 
 inte-
grin expression include PDGF (Ahlen and Kristofer,
1994), TGF-
 
b
 
 (Riikonen et al., 1995
 
b
 
), EGF (Fujii et al.,
1995), PMA (Xu et al., 1996), and oncogenes Erb-B2 and
v-ras (Ye et al., 1996). The mechanisms underlying the
 
a
 
2
 
b
 
1
 
 expression stimulated by 3D COL remain unclear.
Previously we have presented evidence that a second mes-
senger pathway elicited by 3D COL, which involves pro-
tein kinase C–
 
z
 
, can mediate integrin 
 
a
 
2
 
 mRNA expres-
sion (Xu and Clark, 1997). A recent report showed that
other second messenger proteins are modulated by 3D
COL such as the suppression of p70 S6 kinase and the ele-
vated levels of p27
 
Kip1
 
 and p21
 
Cip1/Waf1
 
, inhibitors of cyclin-
dependent kinase 2 (cdk2) (Koyama et al., 1996). The 3D
COL was also reported to regulate the transcription ma-
chinery. For example, the transcription of collagen (Eckes
et al., 1993) and albumin (Caron, 1990) genes is downregu-
lated by 3D COL. The DNA binding activity of nuclear
transcription factors has been found to be directly regu-
lated by 3D COL. Nuclear extracts of hepatocytes cul-
tured in 3D COL demonstrated induction of DNA binding
activity to a TGTTTGC sequence that occurs at regulatory
sites of several hepatic genes including albumin, a 3D COL–
responsive gene (DiPersio et al., 1991; Liu et al., 1991). We
showed previously that fibroblasts cultured in 3D COL in-
creased DNA binding activity of nuclear factor (NF)-
 
k
 
B
(Xu and Clark, 1997), a transcription factor that activates
gene transcription by binding to a 
 
k
 
B sequence motif in
the promoter of responsive genes after release from an in-
active cytoplasmic complex and translocation to the nu-
cleus (for review see Baeuerle and Baltimore, 1996).
A number of studies have addressed the intimate associ-
ation between the NF-
 
k
 
B/Rel family of transcription factors
and cell adhesion events. First, activation of NF-
 
k
 
B can be
caused by the adhesion of cells to fibronectin including
human gingival fibroblasts, monkey smooth muscle cells
(Qwarnstrom et al., 1994), and human monocytic cell line
THP-1 (Lin et al., 1995
 
a
 
). The cell-binding domain and the
heparin-binding domain of fibronectin molecule were re-
ported to mediate the NF-
 
k
 
B activation (Qwarnstrom et al.,
1994). Integrins are considered a critical player in this pro-
cess since the ligation to 
 
b
 
1 integrins to antibody also
induces NF-
 
k
 
B activity comparable to cell adhesion to fi-
bronectin (Lin et al., 1995
 
a
 
). Second, NF-
 
k
 
B activity is re-
quired for the expression of a group of genes encoding
cells adhesion molecules such as vascular cell adhesion
molecule–1 (VCAM-1), E-selectin, intercellular adhesion
molecule–1, and mucosal addressin cell adhesion mole-
cule–1 (for review see Baldwin, 1996). VCAM-1, a cell sur-
face protein typically found on endothelial cells upon stim-
ulation by tumor necrosis factor (TNF)-
 
a
 
, interleukin
(IL)-1, or lipopolysaccharide, binds circulating monocytes
and lymphocytes expressing 
 
a
 
4
 
b
 
1
 
 or 
 
a
 
4
 
b
 
7
 
 integrins and
likely participates in the recruitment of these cells to sites
of tissue injury (Elices et al., 1990; Chan et al., 1992). Ad-
ditionally, NF-
 
k
 
B seems directly involved in the adhesion
of murine embryonic stem cells to various ECM such as
gelatin, fibronectin, laminin, and type IV collagen. Anti-
sense RelA oligonucleotides (and in some instances anti-
sense p50 oligonucleotides) administered to various cells,
including embryonal stem cells, cause complete detach-
ment from the substratum (Narayanan et al., 1993; Soko-
loski et al., 1993). Also, PMA-induced adhesion of HL-60
cells could be inhibited by competitive binding of NF-
 
k
 
B
in vivo (Eck et al., 1993).
Little is known about the reciprocal regulation between
NF-
 
k
 
B and 3D ECM. In the present study, we character-
ized the activation of NF-
 
k
 
B and its role in integrin 
 
a
 
2
 
gene expression by 3D COL. We show in this report that
the 3D COL can induce the nuclear translocation of p50,
that NF-
 
k
 
B activity was required for the induction of inte-
grin 
 
a
 
2
 
 expression by 3D COL at promoter activity, steady-
state mRNA level, and protein level, and that a promoter
region conferred 3D COL inducibility. Finally, we demon-
strate that NF-
 
k
 
B activity appeared to be required for fi-
broblast-mediated contraction of 3D collagen matrices.
 
Materials and Methods
 
Cell Culture and Reagents
 
Human fibroblast cultures established by outgrowth from healthy human
skin biopsies were provided by M. Simon (SUNY, Stony Brook, NY). The
cells were maintained in DME (GIBCO-BRL, Gaithersburg, MD), sup-
plemented with 10% FCS (Hyclone, Logan, UT), 100 U/ml penicillin, 100
U/ml streptomycin (GIBCO-BRL), and grown in a humidified atmosphere
of 5% CO
 
2
 
 and 95% air at 37
 
8
 
C. Cells between population doubling levels
15 and 20 (the 6th and 10th passage) were used for the experiments. Bisin-
dolylmaleimide GF 109203X (BIM) was purchased from CalBiochem-
Novabiochem Corp. (La Jolla, CA). SN50 was obtained from BIOMOL
(Plymouth Meetings, PA). The control peptide of SN50, SM, was synthe-
sized by Research Genetics Inc. (Huntsville, AL) based on published se-
quences (Lin et al., 1995
 
b
 
). Polyclonal antibodies against NF-
 
k
 
B p65, p50,
c-Rel, RelB, I
 
k
 
-B
 
a
 
, and monoclonal antibody against Sp1 were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against
 
b
 
-tubulin and human integrin 
 
a
 
2
 
 subunit were purchased from Chemicon
International, Inc. (Temecula, CA). [
 
14
 
C]Chloramphenical, [
 
a
 
-
 
32
 
P]dCTP,
and [
 
g-32P]ATP were obtained from DuPont-NEN (Boston, MA).
Plasmids and Oligonucleotides
Plasmids basicCAT and cytomegalovirus-CAT have been described previ-
ously (Zutter et al., 1994). Plasmids RSV–b-galactosidase, human a2
cDNA probe, wild-type IkB-a, and constitutive IkB-a32, 36 were provided
by L. Taichman (SUNY), Y. Takada (The Scripps Institute, La Jolla, CA)
(Takada and Hemler, 1989), W. Greene (The Gladstone Institute of Vi-
rology and Immunology), respectively. Human MMP-1 cDNA and a5
cDNA were purchased from American Type Culture Collection (Rock-
ville, MD) and GIBCO-BRL, respectively. An oligonucleotide comple-
mentary to 28S ribosomal RNA was purchased from CLONTECH (Palo
Alto, CA). NF-kB and Sp1 enhancer element consensus sequences 59-
AGT TGA GGG GAC TTT CCC AGG C-39 and 59-ATT CGA TCG
GGG CGG GGC GAG C-39, respectively, were purchased from Promega
Corp. (Madison, WI). The four repeats of NF-kB consensus element (GG-
GACTTTCC) as well as four repeats of its mutated sequence (AT-
CACTTTCC; mutated bases are underlined) were synthesized and in-
serted, respectively, into the BamHI site of a promoter-CAT vector
purchased from Promega Corp. The construction of a series of a2CAT
plasmids has been described previously (Zutter et al., 1994). For the oppo-
site orientation of an upstream sequence of a2 promoter (2549 through
2351), the DNA fragment was digested with restriction enzymes (BglII
and SmaI), filled in at 39 end, and ligated back into the vector. Deletion
mutant, pa2549.dis, was made by restriction enzyme digestion of frag-
ments (2351 through 2122 by SmaI and SacII) from pa2549CAT. A sec-
ond deletion mutant, pa2549.del, was made by removing a fragment
(2549 though 2351) from pa2776CAT by BglII and SmaI followed by fill-
ing in and ligation. For SV-40 promoter–CAT constructs, the a2 promoter
fragment (2549 through 2351) in both orientations was inserted into theXu et al. Integrin Regulation by Extracellular Matrix 711
BamHI site of the vector. The correctness of the recombinant DNA work
was confirmed through restriction digest analysis. The PCR protocol for
generating promoter fragments used in DNA–protein binding reaction
was as follows: 20 ng of DNA template was amplified at 948C for 2 min,
followed by 30 cycles of 948C for 1 min, 558C for 1 min, and 728C for 30 s in
a programmable thermal controller (PTC-100, Model 60; MJ research,
Watertown, MA). The sequences of primers used are: pair 1 (59-
2590GTATTGCTTAAATATCA2573-39; 59-2514AGGTTAGAAACTAA-
CTC2531-39); pair 2 (59- 2516CTGGTCATTCTGCGCTTA2498-39; 59- 2413CAC-
TAGCCCTAAACCACA2431-39); and pair 3 (59- 2415GTGCCCTCGG-
ACCCCGCT2397-39; 59- 2342AGTCCCCGGGAGAACGTG2360-39).
Preparation of COLs
Collagen gels were prepared according to a procedure previously de-
scribed (Xu and Clark, 1996). Pepsin-solubilized bovine dermal collagen
dissolved in 0.012 M HCl was 99.9% pure containing 95–98% type I col-
lagen and 2–5% type III collagen (Vitrogen 100; Celltrix Laboratories,
Palo Alto, CA). Collagen for cultures was prepared by mixing 2.0 mg/ml
of type I collagen, 100 U/ml penicillin, 100 U/ml streptomycin, and 1%
FCS in DME, pH 7.0–7.4. Human dermal fibroblasts from subconfluent
cultures starved in 1% FCS for 24 h were mixed with collagen solution for
a final concentration of 5 3 105 cells/ml. The collagen cell suspension (4 ml)
was immediately placed onto 2% BSA-coated (ICN Biomedicals, Aurora,
OH) between, 60-mm petri dishes (Falcon, Becton Dickinson Labware,
Lincoln Park, NJ) and incubated at 378C for 2 h or for the time periods de-
scribed in figure legends before the addition of 5 ml of 1% FCS/DME to
each dish. In most experiments described here, cells used as control are
cultured in 1% FCS/DME on conventional tissue plastic plates.
After incubation at 378C in 95% air, 5% CO2, and 100% humidity for
the indicated time, cultures were carefully washed twice in DME, and
then processed for various analysis. In experiments where inhibitors were
used, the levels of lactate dehydrogenase activity released were measured
(LD Diagnostic kit; Sigma Chemical Co., St. Louis, MO) and were similar
between cells cultured in the presence or absence of inhibitors. When gel
contraction experiments were performed, the contraction process was ob-
served and photographed at indicated time points. The surface areas of
the gels were measured from prints. Data are presented as relative value
and represent 10 individual experiments.
Coating of Petri Dishes
For monolayer collagen coating of plastic dishes, the collagen used for lat-
tices was diluted to a final concentration of 50 mg/ml with PBS. This solu-
tion was added to plastic dishes at a final concentration of 6.4 mg/cm2 and
incubated overnight at 48C. Coated dishes were blocked with 2% BSA for
2 h at room temperature and rinsed with PBS twice before use.
Northern Analysis of Total Cellular RNA
Total RNA was isolated from cell monolayers and collagen gel cultures
using a modification of guanidinium thiocyanate method (Chromczynski
and Sacchi, 1987). After centrifugation at 14,000 g to remove culture me-
dium, collagen gels were dissolved in 4 M guanidinium isothiocyanate and
repeatedly passed through a 20.5-gauge needle. For Northern blot hybrid-
ization, 3–5 mg of total RNA was treated with glyoxal/DMSO, separated
by electrophoresis on an 1% agarose gel in 10 mM phosphate buffer, pH
7.0, and then transferred to Hybond1 nylon membranes (Amersham Corp.,
Arlington Heights, IL). Ethidium bromide (0.5 mg/ml) was included in the
gel to monitor equal loading by the quantity of 18S and 28S ribosomal
RNA present. cDNA probes were labeled with [a-32P]dCTP by the ran-
dom primer procedure (DuPont-NEN, Boston, MA). Oligonucleotide probes
were end labeled with [g-32P]ATP in the presence of polynucleotide ki-
nase (Boehringer Mannheim, Indianapolis, IN). The filters were hybrid-
ized to the labeled probes in QuickHyb solution (Stratagene, La Jolla,
CA) for 3 h at 688C and washed according to manufacturer’s protocol.
The signals were detected by autoradiography (X-Omat AR; Eastman
Kodak, Rochester, NY) at 2808C for optimal exposure. All results shown
are representative of at least two independent experiments.
Western Immunoblotting
4–7 mg of proteins from cytoplasmic and nuclear fractions prepared as
previously described (Xu and Clark, 1997) were separated on SDS–poly-
acrylmide gel and transferred to polyvinylidene difluoride membranes
(Millipore Corp., Bedford, MA). The membranes were incubated with a
blocking solution containing 2% BSA, 2% horse serum, 50 mM Tris, pH
7.5, 150 mM NaCl, and 0.05% Tween 20 for 1 h at room temperature, and
then incubated overnight at 48C with various primary antibodies: p50, Ik-
Ba, b-tubulin, Sp1 and integrin a2 subunit. For detection with enhanced
chemiluminescence (Amersham Corp.), the blot was incubated with
HRP-conjugated goat anti–rabbit antibody (1:1,000 dilution; Amersham
Corp.) in 50 mM Tris, pH 7.5, 150 mM NaCl, and 0.05% Tween 20 for 1 h
at room temperature. For detection with alkaline phosphatase, the mem-
brane was sequentially incubated with biotinylated anti–rabbit goat IgG
(H1L) (Vector Labs., Inc., Burlington, CA) at 6 mg/ml (1:250 dilution),
and alkaline phosphatase at 1:600 dilution, and then visualized by NBT/
BCIP.
Gel Mobility Shift Assay
Gel mobility shift assay was performed as previously described (Xu and
Clark, 1997). NF-kB and Sp1 recognition sequences 59-AGT TGA GGG
GAC TTT CCC AGG C-39 and 59-ATT CGA TCG GGG CGG GGC
GAG C-39, respectively, were purchased (Promega, Madison, WI). These
oligonucleotides as well as PCR-generated DNA fragments were end la-
bled by [g-32P]ATP. The nuclear extracts (3–5 mg) were incubated with 1 mg
poly (dI/dC) (Boehringer Mannheim) and 2 mg BSA (GIBCO-BRL) in a
binding buffer (10 mM Tris, pH 7.9, 5 mM MgCl2, 50 mM KCl, 10% glyc-
erol, and 1–5 3 104 cpm end-labeled oligonucleotides) for 20 min at room
temperature. The samples were separated on a 5% native polyacrylamide
gel in 0.53 TBE buffer (Tris-borate-EDTA). For supershift assays, 2 ml
antibodies were added to the reaction mixture containing end-labeled oli-
gonucleotides, and then incubated for additional 30 min at room tempera-
ture. The samples were separated on a 3.5% native polyacrylamide gel.
DNA Transfection
DNA transfection was performed as previously described with a few mod-
ifications (Xu et al., 1996). Cells were passaged at 5–7 3 105 per 10-cm
plate. Transfection was performed 22–24 h after passage. Cotransfection
was performed with either two plasmids, pa2-CAT and pRSV-bgal con-
trol DNA (15 mg each plasmid), or three plasmids, wild-type or constitu-
tive IkB-a32, 36, pa2–CAT, and pRSV–bgal control DNA (10 mg each), in
1 ml 0.25 M CaCl2 were added dropwise to 1 ml 23 HEBS (50 mM Hepes,
pH 7.05, 280 mM NaCl, 1.5 mM Na2HPO4) to form a precipitate. Cells in
plates were rinsed twice with DME. Precipitate was added to the plate
and incubated for 20 min at 378C in 5% CO2. DME containing 10% FBS
and 50 mM chloroquine was added to 10 ml. After 4 h, medium was re-
placed with 0.5% FCS. After 40 h, the transfected cells were trypsinized,
washed twice with PBS, and then subcultured into collagen gel or onto ei-
ther tissue plastic or collagen-coated surface for 18–24 h in 0.5% FCS.
Protein extracts were prepared after cells were released from 3D COL
(Xu and Clark, 1997), and CAT enzyme activity was analyzed as described
previously (Xu et al., 1996).
Results
The 3D COL Induces NF-kB Activity
Previously we observed that 3D COL induces integrin a2
mRNA expression by activating protein kinase C (PKC)-z
(Xu and Clark, 1997). PKC-z has been shown to play an
essential role in activating NF-kB by dominant-negative
PKC-z blocking TNF-a–stimulated NF-kB activity and con-
stitutively active PKC-z activating NF-kB in NIH 3T3 cells
(Diaz-Meco et al., 1993, 1994; Dominguez et al., 1993; Fol-
gueira et al., 1996). We also obtained evidence that the DNA
binding activity of NF-kB, along with the activation of
PKC-z and integrin a2 mRNA expression, is induced by 3D
COL (Xu and Clark, 1997). Here we examined whether
3D COL can signal the induction of transactivating activ-
ity of NF-kB in human dermal fibroblasts. A kB-CAT re-
porter plasmid was constructed by inserting four repeats
of NF-kB consensus element into an SV-40 promoter
CAT reporter plasmid vector. Fibroblasts were trans-The Journal of Cell Biology, Volume 140, 1998 712
fected with the plasmid followed by subculture in 3D COL.
As shown in Fig. 1 A, 3D COL induced transactivating
activity of NF-kB, consistent with the observation made in
DNA binding activity (Xu and Clark, 1997). A control plas-
mid containing the mutant NF-kB recognition sequences
did not demonstrate the inducibility by 3D COL (Fig. 1 A).
The composition of the NF-kB DNA-binding complex was
examined next by gel mobility supershift assay. The p50
and p65(RelA) of NF-kB family were found present in the
binding complex (Fig. 1 B). The composition of the DNA-
binding complex remained unchanged during full time-
course (24 h) of the induction examined (data not shown).
Although the precise mechanisms underlying the NF-kB
induction remain unclear, it is known that the dissociation
of NF-kB from IkB, with which it is sequestered as an in-
active precursor, and the translocation of NF-kB from cy-
toplasm to the nucleus are prerequisite for the subsequent
nuclear activity of NF-kB. To assess whether nuclear activ-
ity of NF-kB observed in Fig. 1 is secondary to its translo-
cation, subcellular fractions from cells cultured in 3D COL
were prepared and immunoblotted for p50, one of two
subunits that were found in the DNA-binding complex
of NF-kB in response to 3D COL (Fig. 1 B). The nuclei
isolated from cells incubated in 3D COL from 30 min to 24 h
showed the presence of p50 in contrast to those from cells
grown on tissue culture (Fig. 2 A). As a control, Sp1, the
transcription factor that binds to its recognition site inde-
pendent of 3D COL induction (Xu and Clark, 1997),
showed the unchanged nuclear protein level during the
time-course of incubation in 3D COL (Fig. 2 A). The ki-
netics of protein levels of NF-kB inhibitory protein, IkB,
was also examined. Whereas Ik-Bb is not detectable in
adult dermal fibroblasts (data not shown), Ik-Ba was de-
tected in the cytoplasmic fractions of quiescent cells (Fig.
2  B, lane 1). The accumulation of Ik-Ba markedly de-
creased 1 h after cells were cultured in 3D COL and then
resynthesized after 4 h (Fig. 2 B). This observation is in ac-
cord with the autoregulation of Ik-Ba by signals that stim-
ulate NF-kB activation via Ik-Ba degradation (Sun et al.,
1993). The detection of b-tubulin in the same sample prep-
arations confirmed the specificity of Ik-Ba decrease (Fig. 2
B). Thus, a correlation was observed between 3D COL
stimulation and NF-kB activation, probably by regulating
the cellular level of Ik-Ba.
NF-kB Mediates Integrin a2 mRNA Expression 
Stimulated by 3D COL
Next we examined the role of NF-kB in the induction of
integrin a2 mRNA expression by 3D COL. Since p50 re-
sponded to a 3D COL signal by undergoing nuclear trans-
location (Fig. 2 A) and forming NF-kB DNA-binding com-
plexes (Xu and Clark, 1997), a cell-permeable synthetic
peptide inhibitor, SN50—which carries the hydrophobic
region of the signal peptide sequence from Kaposi’s fibro-
blast growth factor (K-FGF) linked to the nuclear localiza-
tion sequence (NLS) of p50 (Lin et al., 1995b)—was used
to inhibit NF-kB activity in fibroblasts. SN50 has been re-
ported to specifically inhibit the nuclear translocation of
NF-kB in intact cells such as murine endothelial LE-II cells
and human monocytic THP-1 cells stimulated by TNF-a
and lysophosphatidic acid (LPA) (Lin et al., 1995b). The
effectiveness of SN50 in inhibiting NF-kB activity stimu-
lated by 3D COL in adult human dermal fibroblasts was
examined. As shown in Fig. 3 A, NF-kB DNA binding ac-
tivity was inhibited by the presence of SN50 in a concentra-
tion-dependent manner. In contrast, one control peptide,
SM, which contains the same signal peptide sequence from
K-FGF linked to a random amino acid sequence instead of
p50 NLS (Lin et al., 1995b), did not show measurable in-
Figure 1. 3D collagen lattice induces NF-kB activation. (A) Nor-
mal human dermal fibroblasts were transfected with a CAT re-
porter plasmid that contains 43 kB consensus sequence before
stimulation by collagen gel for 18–24 h. CAT activity was assayed
and subjected to TLC. T, tissue culture; C, collagen gel; Vector,
plasmid without 43 kB; kB, plasmid with 43 kB; mkB, plasmid
with mutated 43 kB. (B) Gel mobility supershift assay was per-
formed with nuclear extracts prepared from fibroblasts grown on
tissue culture plates (TC) or collagen gel (COL). The results
shown are representative of four independent experiments. S1,
anti-P50–NF-kB–DNA complex; S2, anti-P65–NF-kB–DNA com-
plex. NF-kB, (p50-p65)–DNA complex.
Figure 2. 3D COL induces
nuclear translocation of NF-kB
and degradation of IkB-a.
Nuclear extracts (A) and cy-
toplasmic fractions (B) were
prepared from normal hu-
man dermal fibroblasts grown
in collagen gel for indicated
length of time. Western anal-
ysis was performed with anti-
bodies against p50, Sp1, Ik-Ba,
and b-tubulin. The blots were
visualized by enhanced chemi-
luminescence methods as de-
scribed in the Materials and
Methods. The results are rep-
resentative of two indepen-
dent experiments.Xu et al. Integrin Regulation by Extracellular Matrix 713
hibitory effects on the DNA binding of NF-kB stimulated
by 3D COL (Fig. 3 A). To rule out the possibility that the
inhibition of NF-kB DNA binding by SN50 is a nonspecific
effect we examined the DNA binding ability of the SN50-
treated nuclear extracts to Sp1 recognition sequence. The
treatment of fibroblasts with SN50 did not prevent Sp1
from binding to its specific sequence (Fig. 3 A).
We next measured integrin a2 mRNA level from cells
treated with SN50. The mRNA levels of MMP-1 and inte-
grin  a5 were measured in parallel. The 28S ribosomal
RNA was measured as control for gel loading. SN50 inhib-
ited the mRNA levels of integrin a2 and MMP-1, but not
integrin a5 (Fig. 3 B). These results suggest that NF-kB
plays an important role in the regulation of integrin a2 and
MMP-1 expression by 3D COL.
3D COL Induces the Promoter Activity of
Integrin a2 Gene
Since NF-kB is a transcription factor, the requirement of
its activity in 3D COL stimulation of integrin a2 mRNA
expression indicates that 3D COL may control the tran-
scription of integrin a2 gene. To assess this possibility, we
examined whether 3D COL regulates the promoter activ-
ity of integrin a2 gene. The promoter region of the integrin
a2 gene was cloned and a series of deletion mutants of 59
flanking sequence were inserted into a CAT reporter vec-
tor (Fig. 4 A) (Zutter et al., 1994, 1995b). Fibroblasts were
transiently transfected with these CAT reporter constructs
followed by incubation in 3D COL or on two-dimensional
surfaces. As shown in Fig. 4 B, the reporter gene directed
by sequences upstream of 292 bp of integrin a2 promoter
(pa2122CAT, pa2351CAT, pa2549CAT, and pa2776CAT)
showed inhibited basal expression when compared to the
activity of pa292CAT (Fig. 4 B), indicating the presence of
potential silencer element(s). Upon stimuilation by 3D
COL, the upstream sequences up to 2351 bp of integrin a2
promoter (pa292CAT, pa2122CAT, and pa2351CAT) did
not show a positive response. In contrast, the plasmids
containing either 2549 or 2776 bp of upstream sequences
(pa2549CAT and pa2776CAT) demonstrated 3D COL in-
ducibility. Therefore a region located between 292 and
2122 bp probably has negative regulatory sequences for
basal promoter activity, whereas the sequences located be-
tween 2549 and 2351 bp of integrin a2 promoter appear
to modulate positive response to 3D COL. For the conve-
nience of this report, we designate this region a2
549–351. To
understand whether the positive response to 3D COL is
elicited by collagen signals resident in collagen molecules
of any form or a special collagen structure, we cultured fi-
broblasts transfected with pa2549CAT on tissue plastic
plates, on monolayer collagen-coated plates, and in 3D COL.
Cells grown on collagen-coated plates failed to induce re-
porter gene activity when compared to cells grown on
Figure 3. NF-kB mediates
induction of integrin a2 by
3D COL. (A) Gel mobility
shift assay with nuclear ex-
tracts prepared from fibro-
blasts pretreated with SN50
or SM for 30 min, and subcul-
tured in 3D COL for 20 h in
the presence or absence of
SN50. Labeled oligonucle-
otide probes are the consen-
sus sequences for NF-kB and
Sp1. (B) Fibroblasts were
cultured under the same con-
dition as A. Total RNA was
isolated and subjected to
Northern blotting analysis.
The results represent two in-
dependent experiments. SN50,
an inhibitor for NF-kB nu-
clear translocation; SM, a con-
trol peptide for SN50.
Figure 4. Effect of 59 deletion on the expression of integrin a2-
CAT fusion gene induced by 3D COL. (A) The 59 flanking region
of integrin a2 gene fused to the CAT structural gene. These con-
structs were deletion mutants derived from a pa2961-CAT (Zutter
et al., 1994). (B) Fibroblasts were cotransfected with the 59 dele-
tion mutant-CAT and RSV–b-galactosidase fusion genes fol-
lowed by subculture in 3D COL as described in the Materials and
Methods. (C) Fibroblasts were cotransfected with pa2549-CAT
and RSV–b-galactosidase fusion genes followed by subculture on
tissue culture plastic plates (TC), collagen-coated surface (mCOL),
and 3D COL. Cells were harvested 1 d after subculture and cell
extracts were assayed for CAT activity. The results represent at
least five independent experiments. RSV–b-galactosidase activity
was used as a control. pCMV, cytomegalovirus promoter-CAT
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plastic surface (Fig. 4 C), supporting our previous observa-
tions of a2 mRNA (Xu and Clark, 1997). Therefore signals
from collagen in a particular 3D structure seemed respon-
sible for the positive response of a2 promoter modulated
by a2
549–351.
To further confirm that the positive response conferred
by  a2
549–351 is an enhancer-like response, we examined
a2
549–351 based on the classic definition of an enhancer ele-
ment: orientation- and distance-independent activity. A
second set of CAT reporter plasmids were constructed
that include inverted orientation of a2
549–351 (pa2549.rev-
CAT), the altered distance of a2
549–351 relative to the tran-
scription initiation site by deletion of the sequence be-
tween 2351 and 2122 bp from pa2549CAT (pa2549.
disCAT), and the deletion of a2
549–351 from pa2776CAT
(pa2549.delCAT) (Fig. 5 A). Fibroblasts transfected with
this set of plasmids were compared to those with pa2549
CAT, the plasmid containing natural orientation of a2
549–351.
3D COL induced CAT level directed from integrin a2 pro-
moter region (pa2549) was mediated by a2
549–351 since the
deletion of this region from pa2776 (pa2549.del) abrogated
3D COL inducibility of the reporter plasmid (Fig. 5 A),
confirming the inability of pa2351 to respond to 3D COL
stimulation (Fig. 4 B). The 3D COL response mediated by
a2
549–351 was also independent of either its orientation or
its distance to the transcription initiation site since both
reporter plasmids (pa2549.revCAT and pa2549.disCAT)
showed the similar 3D COL response compared to natural
parental reporter plasmid pa2549CAT (Fig. 5 A). Further-
more, the deletion of a region between 2351 and 2122 in
pa2549.disCAT did not restore the basal promoter activity
(Fig. 5 A), indicating the importance of the region be-
tween 292 and 2122 in its negative regulation as demon-
strated by pa2122 (Fig. 4 B).
To test whether a2
549–351 alone is sufficient for 3D COL
induction, we examined the function of this region in a dif-
ferent promoter context. The a2
549–351 was inserted in ei-
ther natural or inverted orientation into an SV-40 pro-
moter-CAT vector lacking of enhancer elements (Fig. 5 B).
3D COL induced CAT activity directed from the SV-40
promoter in the presence of a2
549–351 in either orientation,
but failed to do so in its absence (Fig. 5 B). Taken to-
gether, these results indicate that 3D COL regulated inte-
grin a2 gene expression at transcription level and that a
promoter region between 2549 and 2351 bp was neces-
sary and sufficient for the transcriptional stimulation by
3D COL to occur.
NF-kB Mediates Integrin a2 Gene Transcription 
Stimulated by 3D COL
The requirement of the NF-kB for 3D COL induction of
a2 promoter activity was investigated. Fibroblasts trans-
fected with a2
549–351-containing plasmid (pa2549CAT)
were treated with SN50 or its peptide control, SM. SN50
but not SM, inhibited CAT activity directed by 2549 bp of
integrin a2 promoter stimulated by 3D COL (Fig. 6 A),
consistent with the observation made at mRNA steady-
state level (Fig. 3 B). A PKC inhibitor, BIM, also inhibited
the promoter activity, supporting our previous finding that
PKC is required for integrin a2 mRNA expression induced
by 3D COL (Xu and Clark, 1997). To further confirm the
inhibitory effects of SN50 on a2 promoter activity induced
by 3D COL, we used a second approach by cotransfection
of cells with a2 reporter plasmids and wild-type IkB-a or a
stable mutant IkB-a32, 36. Since 3D COL led to IkB-a deg-
radation (Fig. 2 B), the IkB-a32, 36 mutant, which is resis-
tant to induced degradation (Traenckner et al., 1995),
could serve as a potent and specific inhibitor for NF-kB
activity (Wang et al., 1996). As shown in Fig. 6 B, whereas
IkB-a32,  36 (IkBDN)-transfected cells did not alter their
basal promoter activity as compared with wild-type IkB-a
(mock) transfected cells, they demonstrated a drastic re-
duction in 3D COL–induced pa2549CAT promoter activ-
ity. In contrast, the mutant IkB-a did not affect the pro-
moter activity of either pa292CAT or pa2351CAT when
the transfected cells were cultured in 3D COL (Fig. 6 B).
Therefore it appears that NF-kB transactivating activity
was required for the a2
549–351-mediated the 3D COL induc-
ibility of integrin a2 promoter.
Analysis of DNA sequence in this region revealed that
a site located between 2457 and 2447 bp (GGGACG-
CACC) shares sequence homology but for one base (un-
derlined) to the NF-kB consensus sequence GGGRN-
NYYCC (R indicates purine; N is any base; Y is pyrimidine)
present in a set of inducible genes expressed by human
Figure 5. Effects of orientation, altered distance relative to the
transcription initiation site, and a different promoter context on the
3D COL indicibility of the upstream sequence from 2549 to 2351.
(A) A 59 flanking region between 2549 and 2351 bp was rear-
ranged in the pa2549-CAT by inverted orientation (pa2549.rev)
and different distance relative to the transcriptional initiation
site (pa2549.dis). The region was deleted from pa2776-CAT
(pa2549.del).  pa2549.rev, inverted orientation of the region (2549
through  2351) in pa2549-CAT construct; pa2549.dis, fusion of
the region (2549 through 2351) to 2122 by deletion of a se-
quence fragment from 2351 to 2122 in the pa2549-CAT con-
struct. pa2549.del, deletion of the region (2549 through 2351) in
pa2776-CAT construct. (B) A 59 flanking region spanning be-
tween 2549 and 2351 bp was inserted into an SV-40 promoter-
CAT vector in different orientations; pSV40.pos, natural orienta-
tion of the region (2549 through 2351) inserted in SV-40–CAT
constructs; and pSV40.neg, inverted orientation of the region
(2549 through 2351) inserted in SV-40–CAT constructs. Fibro-
blasts were transfected with these constructs and assayed as de-
scribed in Fig. 4. The results represent at least four independent
experiments. bCAT, CAT vector that lacks upstream regulatory
elements;  pCMV, cytomegalovirus promoter–CAT construct.
Mock, plasmid-minus transfection.Xu et al. Integrin Regulation by Extracellular Matrix 715
monocytic and endothelial cells (Parry and Mackman,
1994). The oligonulceotides synthesized based on this se-
quence, however, mediated neither DNA–protein complex
formation as judged by gel mobility shift assay nor transac-
tivation when inserted into an SV-40 promoter-CAT re-
porter vector as judged by CAT analysis of transfected
cells cultured in 3D COL (data not shown). The observa-
tion raised a possibility that a2 promoter context is re-
quired for the detection of NF-kB binding activity to the
region. Nuclear protein binding of the entire a2
549–351 re-
gion was thus examined. Three DNA fragments were gen-
erated by PCR: F1, 2590 and 2514 bp; F2, 2516 and
2413 bp; and F3, 2415 and 2342 bp (Fig. 7 A). Gel mobil-
ity shift assay showed the formation of three specific F2–
protein complexes, which were moderately increased by
3D COL (Fig. 7 B) whereas F1 and F3 did not demonstrate
the specific nuclear protein binding (data not shown). Three
approaches were taken to determine whether NF-kB was
directly involved in the F2-protein complexes. First, the
DNA binding activity of 3D COL–induced nuclear pro-
teins to F2 region of a2 promoter was reduced to approxi-
mately basal level by the incubation of cells with SN50, the
p50 nuclear translocation inhibitor (Fig. 7 B), suggesting
NF-kB activity is required for the binding complex forma-
tion. However, the competition with unlabeled NF-kB
consensus sequence did not affect the DNA complex for-
mation on F2 (data not shown), suggesting the absence of
direct contact of NF-kB with this DNA fragment. Third,
supershift assays with antibodies against various proteins
of NF-kB family did not yield band shifts (data not shown),
supporting the failure of NF-kB to bind this promoter re-
gion. Therefore, NF-kB appears to play a critical role in in-
tegrin a2 promoter activation by 3D COL through a2
549–351
without direct binding to the region. 
NF-kB Mediates Collagen Gel Contraction
It has been reported by various laboratories that integrin
a2b1 mediates reorganization and contraction of collagen
gels by human cells including fibroblasts (Schiro et al.,
1991), cutaneous squamous carcinoma cells (Fujii et al.,
1995), retinal pigment epithelial cells (Kupper and Fergu-
son, 1993), and transformed osteosarcoma cells (Riikonen
et al., 1995). It was proposed that stimulants such as EGF
(Fujii et al., 1995) and TGF-b (Riikonen et al., 1995b) in-
duce 3D COL contraction by increasing integrin a2b1 ex-
pression. The transfection of integrin a2 cDNA into a cell
line RD cells that expresses b1 chain but possess a very low
level of a2b1 integrin restores the ability of RD cells to
contract collagen gels (Schiro et al., 1991). We hypothe-
sized that since NF-kB mediated a2 gene expression, it
may be in the regulatory pathway leading to a2-mediated
collagen gel contraction. The effects of NF-kB on 3D COL
contraction by fibroblasts were examined. Treatment of
cells with SN50, but not SM, significantly slowed the con-
traction process during 72 h examined (Fig. 8, A and B).
Figure 6. NF-kB mediates induction of integrin a2 promoter ac-
tivity by 3D COL. (A) Fibroblasts cotransfected with pa2549-
CAT and RSV–b-galactosidase fusion gene constructs were pre-
treated with SN50 or SM for 30 min before stimulation by 3D
COL for 18 h. (B) Fibroblast were cotransfected with pa2549-
CAT, RSV–b-galactosidase fusion gene, and either wild-type
IkB-a (Mock) or constitutive IkB-a32, 36 (IkBaDN). CAT activity
was assayed and subjected to TLC. BIM, a protein kinase C in-
hibitor. The results represent at least four independent experi-
ments.
Figure 7. NF-kB mediates DNA–protein binding complex for-
mation on integrin a2 promoter induced by 3D COL. (A) Three
DNA fragments were generated by PCR using integrin a2 pro-
moter as template and used for gel mobility shift assay. F1, DNA
fragment spanning from 2590 to 2514 bp; F2, DAN fragment
spanning from 2516 to 2413 bp; F3, DNA fragment spanning
from 2415 to 2342 bp. (B) Nuclear extracts were prepared from
fibroblasts grown in 3D COL for the time periods as indicated
and from cells grown in 3D COL for 4 h with or without SN50.
Gel mobility shift assay was performed using labeled F2, an up-
stream sequence of integrin a2 (2516 to 2413 bp). Unlabeled F2
was used as DNA competitor. The results represent two indepen-
dent experiments. F2, specific F2–protein complexes; NS, non-
specific binding.The Journal of Cell Biology, Volume 140, 1998 716
The expression of integrin a2 protein by fibroblasts cul-
tured in 3D COL was similarly reduced by SN50 but not
SM (Fig. 8 C). The amount of a nonspecific band of low
molecular weight, serving as an internal control, was simi-
lar in all conditions (Fig. 8 C), confirming the specificity of
the inhibtion. Therefore, it further indicates that NF-kB
was involved in the integrin a2 gene expression stimulated
by 3D COL and tissue reorganization possibly by main-
taining cellular level of integrin a2.
Discussion
We report here that NF-kB activity mediated the expres-
sion of integrin a2 gene induced by 3D COL and the con-
traction of 3D COL populated by adult human dermal fi-
broblasts. The conclusion is supported by four lines of
evidence described in this report. First, 3D COL induced
nuclear translocation of p50, an NF-kB subunit, and the
degradation and resynthesis of IkB-a (Fig. 2, A and B), an
inhibitory protein of NF-kB and an NF-kB-responsive
gene product (LeBail et al., 1993; Chiao et al., 1994). Sec-
ond, two inhibitors of NF-kB activity, a nuclear transloca-
tion inhibitor, SN50, and a stable IkB-a mutant, IkB-a32, 36,
both reduced a2 promoter activity that resides in the up-
stream region between 2549 and 2351 bp (Fig. 6, A and
B). Third, SN50 weakened the protein complex formation
in an a2 promoter fragment from 2516 to 2413 bp (Fig. 7 B).
Fourth, SN50 reduced both a2 mRNA (Fig. 3 B) and pro-
tein levels (Fig. 8 C), and slowed down the collagen gel
contraction process (Fig. 8 B). The observation that 3D
COL signaled induction of NF-kB activity is in line of evi-
dence from other laboratories that cell–ECM interactions
are associated with activation of NF-kB (Qwarnstrom et
al., 1994; Lin et al., 1995a; Lofquist et al., 1995) or liver
transcription factors (Liu et al., 1991).
The modulation in Ik-Ba kinetics presents a potentially
critical link between cytosolic regulatory events and nu-
clear transcription in response to 3D COL induction. Like
cytokine, phorbol ester, and lipopolysaccharide, which
stimulate myeloid, epithelial, and fibroblast cells (Beg and
Baldwin, 1993; Brown et al., 1993; Cordle et al., 1993; Hen-
kel et al., 1993; Sun et al., 1993), 3D COL induces the deg-
radation and subsequence resynthesis of Ik-Ba (Fig. 2 B).
Thus 3D COL may be listed as another extracellular signal
that elicits an array of intracellular signal transmitters
leading to posttranslational modification of Ik-Ba with an
eventual consequence of NF-kB activation. Ik-Ba has been
known as a target of many intracellular signals such as ty-
rosine phosphorylation events (Imbert et al., 1996), the
Ras-Raf pathway (Finco and Baldwin, 1993; Li and Se-
divy, 1993), PKC-z (Diaz-Meco et al., 1994), double-
stranded RNA–dependent kinase (Yang et al., 1995),
mitogen-activated protein kinase/extracellular response
kinase (ERK)-1 (Lee et al., 1997), MAP3K-related kinase
(Malinin et al., 1997), and IkB kinase (Zandi et al., 1997).
PKC-z was reported to be associated with Ik-Ba phosphor-
ylation and subsequent NF-kB activation (Diaz-Meco et al.,
1993; Dominguez et al., 1993; Diaz-Meco et al., 1994;
Folgueira, 1996). Along with the evidence in this report
that 3D COL modulated cellular level of Ik-Ba (Fig. 2 B),
is our previous finding that PKC-z activity is induced un-
der the same condition (Xu and Clark, 1997). Therefore, an
attractive hypothesis would be that signals from 3D COL
are transmitted into the nucleus in part through a PKC-
z/Ik-Ba pathway.
Toward investigating the role of NF-kB in a2 gene ex-
pression, we first questioned whether 3D COL induced a2
Figure 8. NF-kB mediates 3D COL contraction. Fibroblasts were
pretreated with SN50, an inhibitor for NF-kB nuclear transloca-
tion, or SM, a peptide control, for 30 min before stimulation by
3D COL. The incubation was continued for 24 h. Cells released
from 3D COL by collagenase digestion were subcultured into 3D
COL for the measurement of gel contraction in the presence of
SN50 or other additives. The surface diameters (A) of 3D COLs
were measured from the photographs (B) taken at 4, 20, 48, and
72 h after subculture. The results represent 10 independent ex-
periments. (C) Western analysis of proteins extracted from fibro-
blasts cultured in 3D COL for 20, 48, and 72 h in the presence of
either SM or SN50. The samples were run on 6% SDS–polyacryl-
amide gel. The blot was detected by an anti-a2 antibody and visu-
alized with alkaline phosphatase/NBT/BCIP method as described
in the Materials and Methods. The integrin a2 subunit is marked
by an arrow. The results represent two independent experiments.Xu et al. Integrin Regulation by Extracellular Matrix 717
transcription. Although several groups have observed 3D
COL induction of a2 mRNA and/or protein steady-state
levels (Klein et al., 1991; Langholz et al., 1995; Xu and
Clark, 1996), it was not known whether the regulation oc-
curs at transcriptional level. In this report an upstream re-
gion between 2549 and 2351 bp was identified to confer
the 3D COL indicibility of a2 promoter (Figs. 4 and 5). We
confirmed the presence of a general silencer between 292
and 2122 bp that suppresses the basal integrin a2 pro-
moter activity as proposed previously (Zutter et al., 1995b).
The stimulated expression by 3D COL was mediated by
sequences upstream of this region, suggesting that 3D
COL could regulate a2 gene transcription in a DNA se-
quence–dependent manner, probably by releasing the neg-
ative impact of the silencer present between 292 and
2122 bp on the promoter activity. A further study of the
DNA binding pattern in the 3D COL–responsive region
from 2549 to 2351 bp revealed that there were three
DNA sequence–specific protein complexes (Fig. 7). Al-
though the regulation of promoter activity by 3D ECM has
not been studied as extensively as those by soluble factors,
a similar study on b-casein gene promoter activity con-
ducted by Schmidhauser et al. (1992) identified a 160-bp
region in the promoter responsible for its activation by 3D
matrigel. In another study, the promoter of TGF-b1 was
found to be downregulated by 3D matrigel (Streuli et al.,
1993). The involvement of NF-kB activity in a2 promoter
activity was investigated using two inhibitors, SN50, a pep-
tide inhibitor for NF-kB nuclear translocation (Lin et al.,
1995b), and IkB-a32, 36, a stable IkB-a that serves to inhibit
NF-kB. Interestingly, whereas NF-kB activity was consis-
tently found to be required for full activation of integrin a2
expression at levels of mRNA steady-state (Fig. 3 B), pro-
tein (Fig. 8 C), and transcription (Fig. 6), as well as for a2
promoter–DNA protein complex formation (Fig. 7 B), there
was no evidence for direct physical involvement of NF-kB
in a2 promoter; this observation is based on competition
experiments with unlabeled NF-kB consensus sequence
and supershift assay with antibodies against NF-kB pro-
teins (unpublished laboratory data). The observation was
further supported by our failure to find any functional ac-
tivity of a near-perfect NF-kB consensus site located in the
region between 2549 and 2351 bp of a2 promoter as
judged by two sets of experiments: gel mobility shift assay
with the synthetic oligonucleotides based on the a2 NF-
kB–like sequence, and functional assay with the site in-
serted into a reported gene vector (unpublished labora-
tory data). Taken together, these observations suggest an
indirect regulatory mechanism by which NF-kB directs the
synthesis of another transcription factor that in turn acti-
vates the integrin a2 promoter. Among many genes known
to be mediated by NF-kB are these transcription factors,
c-myc (Duyao et al., 1990; LaRosa et al., 1994), interferon
regulatory factor 1 (Fujita et al., 1989; Harada et al., 1994),
RelA (Ueberla et al., 1993), p50 (Ten et al., 1992), and a-1
acid glycoprotein/enhancer-binding protein (Lee et al.,
1996). In fact, we found that 3D COL–induced integrin a2
mRNA expression requires newly synthesized protein (Xu
and Clark, 1997), an observation in accord with the syn-
thesis of an intermediary transcription factor induced by
NF-kB. Further studies will be required to address the
identity of these three DNA–protein complexes, their reg-
ulation by 3D COL, and their functional roles in integrin
a2 gene expression.
The physiological role of NF-kB family proteins is under
intensive study. NF-kB has been implicated in biological
and pathological processes such as cell death (Grimm et al.,
1996; Wu et al., 1996), angiogenesis (Shono et al., 1996),
rheumatoid arthritis (Yang et al., 1995), and human cuta-
neous T lymphoma formation (Thakur et al., 1994). The
appropriate regulation of NF-kB activity seems critical for
proper biological function. For example, NF-kB activity is
required for the H2O2-induced tube formation in human
microvascular endothelial cells grown on 3D COL (Shono
et al., 1996) and antitumor properties of antineoplastic agent
taxol in macrophages (Hwang and Ding, 1995). On the
other hand, the constitutive NF-kB activation in IkBa–/–
transgenic mice causes skin defects (Beg et al., 1995) and
severe widespread dermatitis (Klement et al., 1996). The
important role of NF-kB in mediating reorganization and
contraction of 3D COL as reported here adds another po-
tential biological function of NF-kB. The inhibition of NF-kB
activity, which led to inhibited expression of integrin a2 af-
ter 3D COL stimulation, correlated with the inability of
cells to contract collagen gel (Fig. 8). NF-kB, therefore, may
regulate 3D COL contraction through cell surface expres-
sion of a2b1 level. However, it must be noted that other
possibilities cannot be ruled out. For example, we found
that the presence of a2b1 alone, although neccessary, was
not sufficient for the reorganization and contraction of col-
lagen matrices (unpublished laboratory data), suggesting
that the availability of a2b1 receptor and the a2b1-elicited
second mesenger pathway probably present two separate
control levels for 3D COL contraction. Furthermore, the
inhibition of NF-kB by SN50 also decreased the 3D COL–
induced expression of MMP-1 (Fig. 3 B), a protein in-
volved in tissue remodeling. Additionally, NF-kB is strongly
implicated in the transcriptional regulation of several
growth factors and cytokine genes including interferon-b,
IL-1b, IL-2, IL-6, TNF-a and TGF-b1 (for review see Bald-
win, 1996), which might offer another interpretation on
the mechanism whereby NF-kB modulates tissue remodel-
ing. The essential role for NF-kB in reorganization and
contraction of COLs as reported here may present a po-
tentially important nuclear regulatory site for tissue re-
modeling.
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